171 related articles for article (PubMed ID: 18306039)
1. Immunoreactivity of antibodies against transglutaminase-deamidated gliadins in adult celiac disease.
Falini ML; Elli L; Caramanico R; Bardella MT; Terrani C; Roncoroni L; Doneda L; Forlani F
Dig Dis Sci; 2008 Oct; 53(10):2697-701. PubMed ID: 18306039
[TBL] [Abstract][Full Text] [Related]
2. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
3. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
4. Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin.
Heil A; Ohsam J; van Genugten B; Diez O; Yokoyama K; Kumazawa Y; Pasternack R; Hils M
J Agric Food Chem; 2017 Aug; 65(32):6982-6990. PubMed ID: 28721717
[TBL] [Abstract][Full Text] [Related]
5. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
6. [Anti-deamidated gliadin peptides antibodies and coeliac disease: state of art and analysis of false-positive results from five assays].
Lutteri L; Sagot C; Chapelle JP
Ann Biol Clin (Paris); 2010; 68(2):149-56. PubMed ID: 20348047
[TBL] [Abstract][Full Text] [Related]
7. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease.
Rashtak S; Ettore MW; Homburger HA; Murray JA
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):426-32; quiz 370. PubMed ID: 18304884
[TBL] [Abstract][Full Text] [Related]
8. Extension of the celiac intestinal antibody (CIA) pattern through eight antibody assessments in fecal supernatants from patients with celiac disease.
Di Tola M; Marino M; Casale R; Di Battista V; Borghini R; Picarelli A
Immunobiology; 2016 Jan; 221(1):63-9. PubMed ID: 26271834
[TBL] [Abstract][Full Text] [Related]
9. Gamma-gliadin specific celiac disease antibodies recognize p31-43 and p57-68 alpha gliadin peptides in deamidation related manner as a result of cross-reaction.
Diós Á; Elek R; Szabó I; Horváth S; Gyimesi J; Király R; Werkstetter K; Koletzko S; Fésüs L; Korponay-Szabó IR
Amino Acids; 2021 Jul; 53(7):1051-1063. PubMed ID: 34059947
[TBL] [Abstract][Full Text] [Related]
10. Deamidation of gliadin peptides in lamina propria: implications for celiac disease.
Skovbjerg H; Anthonsen D; Knudsen E; Sjöström H
Dig Dis Sci; 2008 Nov; 53(11):2917-24. PubMed ID: 18679797
[TBL] [Abstract][Full Text] [Related]
11. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
12. Deamidated gliadin peptides as targets for celiac disease-specific antibodies.
Mothes T
Adv Clin Chem; 2007; 44():35-63. PubMed ID: 17682339
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to wheat high-molecular-weight glutenin subunits in patients with celiac disease.
Ellis HJ; Lozano-Sanchez P; Bermudo Redondo C; Šuligoj T; Biagi F; Bianchi PI; Corazza GR; De Silvestri A; Bravi E; Katakis I; O'Sullivan CK; Ciclitira PJ
Int Arch Allergy Immunol; 2012; 159(4):428-34. PubMed ID: 22813868
[TBL] [Abstract][Full Text] [Related]
14. Biochemical modifications of gliadins induced by microbial transglutaminase on wheat flour.
Mazzeo MF; Bonavita R; Maurano F; Bergamo P; Siciliano RA; Rossi M
Biochim Biophys Acta; 2013 Nov; 1830(11):5166-74. PubMed ID: 23891939
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
Agardh D
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up.
Volta U; Granito A; Fiorini E; Parisi C; Piscaglia M; Pappas G; Muratori P; Bianchi FB
Dig Dis Sci; 2008 Jun; 53(6):1582-8. PubMed ID: 17985240
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase.
Dahle C; Hagman A; Ignatova S; Ström M
Aliment Pharmacol Ther; 2010 Jul; 32(2):254-60. PubMed ID: 20456302
[TBL] [Abstract][Full Text] [Related]
18. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
Aleanzi M; Demonte AM; Esper C; Garcilazo S; Waggener M
Clin Chem; 2001 Nov; 47(11):2023-8. PubMed ID: 11673371
[TBL] [Abstract][Full Text] [Related]
19. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
[TBL] [Abstract][Full Text] [Related]
20. Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.
de Chaisemartin L; Meatchi T; Malamut G; Fernani-Oukil F; Hosking F; Rault D; Bellery F; Cellier C; Dragon-Durey MA
PLoS One; 2015; 10(8):e0136745. PubMed ID: 26322980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]